Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia
Open Access
- 19 May 2011
- journal article
- Published by Springer Science and Business Media LLC in BMC Pediatrics
- Vol. 11 (1), 38
- https://doi.org/10.1186/1471-2431-11-38
Abstract
Vasopressin is one of the most important physiological stress and shock hormones. Copeptin, a stable vasopressin precursor, is a promising sepsis marker in adults. In contrast, its involvement in neonatal diseases remains unknown. The aim of this study was to establish copeptin concentrations in neonates of different stress states such as sepsis, chorioamnionitis and asphyxia. Copeptin cord blood concentration was determined using the BRAHMS kryptor assay. Neonates with early-onset sepsis (EOS, n = 30), chorioamnionitis (n = 33) and asphyxia (n = 25) were compared to a control group of preterm and term (n = 155) neonates. Median copeptin concentration in cord blood was 36 pmol/l ranging from undetectable to 5498 pmol/l (IQR 7 - 419). Copeptin cord blood concentrations were non-normally distributed and increased with gestational age (p < 0.0001). Neonates born after vaginal compared to cesarean delivery had elevated copeptin levels (p < 0.0001). Copeptin correlated strongly with umbilical artery pH (Spearman's Rho -0.50, p < 0.0001), umbilical artery base excess (Rho -0.67, p < 0.0001) and with lactate at NICU admission (Rho 0.54, p < 0.0001). No difference was found when comparing copeptin cord blood concentrations between neonates with EOS and controls (multivariate p = 0.30). The highest copeptin concentrations were found in neonates with asphyxia (median 993 pmol/l). Receiver-operating-characteristic curve analysis showed that copeptin cord blood concentrations were strongly associated with asphyxia: the area under the curve resulted at 0.91 (95%-CI 0.87-0.96, p < 0.0001). A cut-off of 400 pmol/l had a sensitivity of 92% and a specifity of 82% for asphyxia as defined in this study. Copeptin concentrations were strongly related to factors associated with perinatal stress such as birth acidosis, asphyxia and vaginal delivery. In contrast, copeptin appears to be unsuitable for the diagnosis of EOS.Keywords
This publication has 29 references indexed in Scilit:
- Vasopressin for Refractory Hypotension in Extremely Low Birth Weight InfantsThe Journal of Pediatrics, 2010
- Moderate Hypothermia to Treat Perinatal Asphyxial EncephalopathyThe New England Journal of Medicine, 2009
- Maternal Allopurinol During Fetal Hypoxia Lowers Cord Blood Levels of the Brain Injury Marker S-100BPEDIATRICS, 2009
- Vasopressin and its copilot copeptin in sepsis and septic shock*Critical Care Medicine, 2009
- Associations between serum cortisol, cardiovascular function and neurological outcome following acute global hypoxia in the newborn pigletStress, 2009
- Vasopressin in pediatric shock and cardiac arrestPediatric Critical Care Medicine, 2008
- Terlipressin as rescue treatment of refractory shock in a neonateActa Paediatrica, 2008
- COPEPTIN, A STABLE PEPTIDE OF THE ARGININE VASOPRESSIN PRECURSOR, IS ELEVATED IN HEMORRHAGIC AND SEPTIC SHOCKShock, 2007
- Mode of delivery is associated with maternal and fetal endocrine stress responseBJOG: An International Journal of Obstetrics and Gynaecology, 2006
- Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of VasopressinClinical Chemistry, 2006